Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study
Rheumatology (Oxford). 2021;60(5):2256-2266.
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Rheumatology (Oxford). 2021;60(5):2256-2266.
Wells AF, et al. Rheumatol Ther. 2021. Epub ahead of print. DOI: 10.1007/s40744-021-00317-9.
Int J Clin Pharmacol Ther. 2021. Epub ahead of print.
Rheumatology (Oxford). 2021;60(4):1708-1716.
N Engl J Med. 2021;384(13):1227-1239.
Rheumatology (Oxford). 2021 Mar 22:keab294. Epub ahead of print. DOI: 10.1093/rheumatology/keab294
Front. Cell Dev. Biol. 9:630942 DOI: 10.3389/fcell.2021.630942
Ann Rheum Dis. 2021 Mar 19:annrheumdis-2020-219012. Epub ahead of print. DOI: 10.1136/annrheumdis-2020-219012
Mod Rheumatol. 2021 Mar 19:1-26. Epub ahead of print. DOI 10.1080/14397595.2021.1902617
Drug Saf. 2021 Feb 2. DOI: 10.1007/s40264-020-01036-w